首页 > 最新文献

The European journal of cardiovascular medicine最新文献

英文 中文
Outcome of Interventional Cardiac Catheterization in Infants Weighing Less Than 2500 Grams: A Comparative Study 体重小于2500克的婴儿介入心导管插入术的结果:一项比较研究
Pub Date : 2020-08-02 DOI: 10.5083/ejcm20424884.175
A. Afifi, M. El-Baz, H. A. Elghaiaty, A. Fattouh, H. Hamza
ABSTRACTObjectives: A retrospective study to evaluate the outcome of interventional cardiac catheterization in infants weighing <2500 grams.Background: The mortality of small weight infants undergoing heart surgery remains high, so cardiac catheterization has been utilized to improve the outcome.Methods: The study included infants who underwent interventional cardiac catheterization within the first 60 days of life in New Children Cairo University Hospital, Cairo, Egypt from January 2015 to January 2018. The study group included infants < 2500 grams while the comparative group included infants ≥ 2500 grams. Adverse events were classified according to the mechanism and seriousness.Results: The study group (37 patients) had a mean weight of 2.35 ±0.13 Kg, while the comparative group (164 patients) had a mean weight of 3.54 ±0.71 Kg. The procedures included balloon atrial septostomy, pulmonary balloon valvuloplasty, ductus arteriosus stenting and radiofrequency perforation of pulmonary atresia. The study group showed less success rates as compared with the comparative group (83.8% versus 93.9%, p = 0.04), and higher incidence of overall adverse events (48.6% versus 20.1 %, p<0.001) as well as catheterization-related mortality (29.7% versus 4.9%, P<0.001). In the study group, pulmonary balloon valvuloplasty showed the highest incidence of major adverse events while ductus arteriosus stenting had the highest incidence of mortality.Conclusions: Compared to normal weight infants, interventional cardiac catheterization in small weight infants is associated with lower success and higher morbidity and mortality rates. Pulmonary balloon valvuloplasty and ductus arteriosus stenting have the highest morbidity and mortality, respectively.
目的:对体重<2500克婴儿进行介入性心导管插入术的疗效进行回顾性研究。背景:接受心脏手术的小体重婴儿死亡率仍然很高,因此心导管插入术已被用于改善结果。方法:该研究包括2015年1月至2018年1月在埃及开罗新儿童开罗大学医院接受介入性心导管插入术的婴儿。研究组包括<2500克的婴儿,而比较组包括≥2500克的婴儿。不良事件根据机制和严重程度进行分类。结果:研究组(37例)的平均体重为2.35±0.13 Kg,而对照组(164例)的体重为3.54±0.71 Kg。手术包括球囊心房间隔造口术、肺球囊瓣膜成形术、动脉导管支架置入术和肺动脉闭锁射频穿孔术。与对照组相比,研究组的成功率较低(83.8%对93.9%,p=0.04),总体不良事件发生率较高(48.6%对20.1%,p<0.001),导管插入术相关死亡率较高(29.7%对4.9%,p=0.001),肺球囊瓣膜成形术的主要不良事件发生率最高,而动脉导管支架置入术的死亡率最高。结论:与正常体重婴儿相比,小体重婴儿的介入性心导管插入术成功率较低,发病率和死亡率较高。肺球囊瓣膜成形术和动脉导管支架置入术的发病率和死亡率分别最高。
{"title":"Outcome of Interventional Cardiac Catheterization in Infants Weighing Less Than 2500 Grams: A Comparative Study","authors":"A. Afifi, M. El-Baz, H. A. Elghaiaty, A. Fattouh, H. Hamza","doi":"10.5083/ejcm20424884.175","DOIUrl":"https://doi.org/10.5083/ejcm20424884.175","url":null,"abstract":"ABSTRACT\u0000\u0000Objectives: A retrospective study to evaluate the outcome of interventional cardiac catheterization in infants weighing <2500 grams.\u0000\u0000Background: The mortality of small weight infants undergoing heart surgery remains high, so cardiac catheterization has been utilized to improve the outcome.\u0000\u0000Methods: The study included infants who underwent interventional cardiac catheterization within the first 60 days of life in New Children Cairo University Hospital, Cairo, Egypt from January 2015 to January 2018. The study group included infants < 2500 grams while the comparative group included infants ≥ 2500 grams. Adverse events were classified according to the mechanism and seriousness.\u0000\u0000Results: The study group (37 patients) had a mean weight of 2.35 ±0.13 Kg, while the comparative group (164 patients) had a mean weight of 3.54 ±0.71 Kg. The procedures included balloon atrial septostomy, pulmonary balloon valvuloplasty, ductus arteriosus stenting and radiofrequency perforation of pulmonary atresia. The study group showed less success rates as compared with the comparative group (83.8% versus 93.9%, p = 0.04), and higher incidence of overall adverse events (48.6% versus 20.1 %, p<0.001) as well as catheterization-related mortality (29.7% versus 4.9%, P<0.001). In the study group, pulmonary balloon valvuloplasty showed the highest incidence of major adverse events while ductus arteriosus stenting had the highest incidence of mortality.\u0000\u0000Conclusions: Compared to normal weight infants, interventional cardiac catheterization in small weight infants is associated with lower success and higher morbidity and mortality rates. Pulmonary balloon valvuloplasty and ductus arteriosus stenting have the highest morbidity and mortality, respectively.","PeriodicalId":75000,"journal":{"name":"The European journal of cardiovascular medicine","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42291795","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of Coronary Artery Aneurysm – Report of two cases 冠状动脉瘤的治疗——附两例报告
Pub Date : 2020-07-06 DOI: 10.5083/ejcm20424884.174
K. Jadhav, K. Raju, R. Reddy, K. Sridhar, S. Ramani, SS Mane
Coronary artery aneurysm (CAA) is described as a localized dilatation of a coronary artery segment by more than 1.5-fold compared with the adjacent normal segments. The incidence of CAA varies from 0.3 to 5.3% with atherosclerosis, Takayasu arteritis, congenital disorders, Kawasaki disease, and percutaneous coronary intervention (PCI) being the common etiologic factors. Owing to its varying presentation and absence of robust treatment guidelines, management of CAA is a challenge. Management of every patient must be tailored according to the presentation and expertise of the cardiac team available. Here, we present case reports of two patients with CAA who presented with acute coronary syndrome. As a result of unstable presentation, both patients underwent immediate intervention (CABG and PCI respectively) with successful revascularization having no complication and mortality.
冠状动脉动脉瘤(CAA)被描述为冠状动脉段的局部扩张,比邻近的正常段扩大1.5倍以上。CAA的发生率为0.3 ~ 5.3%,动脉粥样硬化、高松动脉炎、先天性疾病、川崎病和经皮冠状动脉介入治疗(PCI)是常见的病因。由于其不同的表现和缺乏强有力的治疗指南,CAA的管理是一个挑战。每个病人的管理必须根据心脏团队的表现和专业知识量身定制。在这里,我们报告了两例CAA患者的急性冠脉综合征。由于表现不稳定,两名患者均接受了立即介入治疗(分别为冠脉搭桥和PCI),并成功进行了血运重建术,无并发症和死亡。
{"title":"Management of Coronary Artery Aneurysm – Report of two cases","authors":"K. Jadhav, K. Raju, R. Reddy, K. Sridhar, S. Ramani, SS Mane","doi":"10.5083/ejcm20424884.174","DOIUrl":"https://doi.org/10.5083/ejcm20424884.174","url":null,"abstract":"Coronary artery aneurysm (CAA) is described as a localized dilatation of a coronary artery segment by more than 1.5-fold compared with the adjacent normal segments. The incidence of CAA varies from 0.3 to 5.3% with atherosclerosis, Takayasu arteritis, congenital disorders, Kawasaki disease, and percutaneous coronary intervention (PCI) being the common etiologic factors. \u0000\u0000Owing to its varying presentation and absence of robust treatment guidelines, management of CAA is a challenge. Management of every patient must be tailored according to the presentation and expertise of the cardiac team available. Here, we present case reports of two patients with CAA who presented with acute coronary syndrome. \u0000\u0000As a result of unstable presentation, both patients underwent immediate intervention (CABG and PCI respectively) with successful revascularization having no complication and mortality.","PeriodicalId":75000,"journal":{"name":"The European journal of cardiovascular medicine","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-07-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44722855","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Severe Coronary Artery Disease and Metabolic Syndrome in Patients with Acute Coronary Syndrome in South Punjab Region of Pakistan 巴基斯坦南旁遮普地区急性冠状动脉综合征患者的严重冠状动脉疾病和代谢综合征
Pub Date : 2020-06-08 DOI: 10.5083/ejcm20424884.171
G. Niazi, F. Adnan, Saleemi, A. Akhtar, N. Ahmed, ST Shehzad
Background: Hypertension, dyslipidemia, and disturbed glucose metabolism associated with central obesity are often referred to as Metabolic Syndrome (MetS) and patients of MetS have a two- to three-fold increased risk for the development of cardiovascular diseases.Objective: Objectives were to determine the frequency of MetS in patients presenting with acute coronary syndromes and to compare the frequencies of severe coronary artery disease in patients with and without MetS.Methods: This descriptive cross-sectional study included 200 patients with acute coronary syndromes over a period of six months. Frequency of MetS was calculated. The frequencies of severe coronary artery disease were compared between patients having MetS and not having MetS using chi-square chart.Results: Total 200 patients with the mean age of 54.24 ± 9.41 years were included. 131 (65.5%) patients with acute coronary syndrome had MetS. Total 112 patients (56%) had severe coronary artery disease. 63.35% with MetS and 42.03% without MetS had severe coronary artery disease (p=0.003).Conclusion: The frequency of metabolic syndrome was high (65.5%) in patients with acute coronary syndromes and severe coronary artery disease was found to be associated with the presence of metabolic syndrome in these patients.
背景:与中枢性肥胖相关的高血压、血脂异常和糖代谢紊乱通常被称为代谢综合征(MetS), MetS患者发生心血管疾病的风险增加2 - 3倍。目的:目的是确定急性冠脉综合征患者发生MetS的频率,并比较有和没有MetS的患者发生严重冠状动脉疾病的频率。方法:这项描述性横断面研究包括200例急性冠状动脉综合征患者,为期6个月。计算MetS的频率。用卡方图比较met患者和非met患者发生严重冠状动脉疾病的频率。结果:共纳入200例患者,平均年龄54.24±9.41岁。131例(65.5%)急性冠脉综合征患者有MetS。112例(56%)有严重冠状动脉疾病。63.35%的MetS患者和42.03%的非MetS患者有严重冠状动脉疾病(p=0.003)。结论:急性冠状动脉综合征患者代谢综合征发生率高(65.5%),重症冠状动脉病变与代谢综合征存在相关。
{"title":"Severe Coronary Artery Disease and Metabolic Syndrome in Patients with Acute Coronary Syndrome in South Punjab Region of Pakistan","authors":"G. Niazi, F. Adnan, Saleemi, A. Akhtar, N. Ahmed, ST Shehzad","doi":"10.5083/ejcm20424884.171","DOIUrl":"https://doi.org/10.5083/ejcm20424884.171","url":null,"abstract":"Background: \u0000Hypertension, dyslipidemia, and disturbed glucose metabolism associated with central obesity are often referred to as Metabolic Syndrome (MetS) and patients of MetS have a two- to three-fold increased risk for the development of cardiovascular diseases.\u0000Objective: Objectives were to determine the frequency of MetS in patients presenting with acute coronary syndromes and to compare the frequencies of severe coronary artery disease in patients with and without MetS.\u0000\u0000Methods: \u0000This descriptive cross-sectional study included 200 patients with acute coronary syndromes over a period of six months. Frequency of MetS was calculated. The frequencies of severe coronary artery disease were compared between patients having MetS and not having MetS using chi-square chart.\u0000\u0000Results: \u0000Total 200 patients with the mean age of 54.24 ± 9.41 years were included. 131 (65.5%) patients with acute coronary syndrome had MetS. Total 112 patients (56%) had severe coronary artery disease. 63.35% with MetS and 42.03% without MetS had severe coronary artery disease (p=0.003).\u0000\u0000Conclusion: \u0000The frequency of metabolic syndrome was high (65.5%) in patients with acute coronary syndromes and severe coronary artery disease was found to be associated with the presence of metabolic syndrome in these patients.","PeriodicalId":75000,"journal":{"name":"The European journal of cardiovascular medicine","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48088225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiopulmonary Exercise Testing in Percutaneous Mitral Valve Repair: A Single Centre’s Experience 心肺运动试验在经皮二尖瓣修复:单一中心的经验
Pub Date : 2020-06-02 DOI: 10.5083/ejcm20424884.173
K. C. Hou, T. S. Yaw, Y. Keong
Chronic severe mitral regurgitation (MR) confers negative hemodynamic consequences and long-term morbidity and mortality1. The adverse remodeling processes result in the inability of mitral valve leaflets to co-apt optimally in functional MR (FMR)2. Even after optimal medical therapy, or revascularization, FMR may not necessarily be reduced adequately. In such patients who remain persistently symptomatic from residual MR, the next course of management may be the surgical or percutaneous intervention of the mitral valve apparatus. Subsequently, percutaneous repair via transcatheter delivered systems has emerged as the treatment of choice; especially, in patients assessed to be at a high operative risk with a suitable anatomy for minimally invasive approaches to re-appose the mitral leaflets3. This has also revolutionized the approach to the management of primary mitral regurgitation (PMR), such as from mitral valve prolapse. It was treated conventionally by the surgical intervention with mitral valve repair or replacement, allowing an alternative option for the high surgical risk patients 4.In our center, the transcatheter mitral valve repair procedure (MitraClip) has been introduced in the year 2012, providing an option of percutaneous intervention to the patients where MR is unsuitable for the surgical correction. However, persistent symptoms may occur due to the concomitant non-valvular or non-cardiac pathologies, particularly chronic pulmonary diseases. Also, assessment of functional class is subjective and may be confounded by other variables, such as sedentary lifestyle, self-imposed exercise restrictions, or orthopedic conditions.The cardiopulmonary exercise test (CPET) provides an objective assessment of the exercise capacity, obviating the subjective aspects of self-reported symptoms and functional status Besides, CPET is also useful to discern pulmonary and functional status. Besides, CPET is also useful to discern pulmonary and non-cardiac contributory components of the perceived decreased functional capacity, including motivational factors.Multiple CPET parameters, related to hemodynamic surrogates before and after the MitraClip procedure, also enable a more objective evaluation of the cardiovascular impact of the repair, allowing insights into the improvements in cardiac hemodynamics post intervention7-10.
慢性严重二尖瓣反流(MR)会带来负面的血流动力学后果和长期发病率和死亡率1。在功能性磁共振(FMR)中,不利的重塑过程导致二尖瓣小叶无法最佳地适应2。即使经过最佳的药物治疗或血运重建,FMR也不一定会充分减少。对于残留MR症状持续存在的患者,下一个治疗方案可能是手术或经皮二尖瓣介入治疗。随后,经导管输送系统的经皮修复已成为治疗的选择;特别是对于手术风险高的患者,采用合适的解剖结构进行微创入路重新放置二尖瓣3。这也彻底改变了原发性二尖瓣反流(PMR)的治疗方法,如二尖瓣脱垂。传统的治疗方法是手术介入二尖瓣修复或置换,为手术风险高的患者提供了另一种选择。我中心于2012年引入经导管二尖瓣修复术(MitraClip),为MR不适合手术矫正的患者提供经皮介入治疗的选择。然而,伴随的非瓣膜或非心脏病变,特别是慢性肺部疾病,可能会出现持续的症状。此外,对功能等级的评估是主观的,可能会受到其他变量的影响,如久坐的生活方式、自我强加的运动限制或骨科疾病。心肺运动试验(CPET)提供了对运动能力的客观评估,消除了自我报告症状和功能状态的主观方面,此外,CPET还有助于辨别肺部和功能状态。此外,CPET也有助于辨别肺和非心脏的功能容量下降的贡献成分,包括动机因素。与MitraClip手术前后血流动力学替代物相关的多个CPET参数也可以更客观地评估修复对心血管的影响,从而深入了解干预后心脏血流动力学的改善情况7-10。
{"title":"Cardiopulmonary Exercise Testing in Percutaneous Mitral Valve Repair: A Single Centre’s Experience","authors":"K. C. Hou, T. S. Yaw, Y. Keong","doi":"10.5083/ejcm20424884.173","DOIUrl":"https://doi.org/10.5083/ejcm20424884.173","url":null,"abstract":"Chronic severe mitral regurgitation (MR) confers negative hemodynamic consequences and long-term morbidity and mortality1. The adverse remodeling processes result in the inability of mitral valve leaflets to co-apt optimally in functional MR (FMR)2. Even after optimal medical therapy, or revascularization, FMR may not necessarily be reduced adequately. In such patients who remain persistently symptomatic from residual MR, the next course of management may be the surgical or percutaneous intervention of the mitral valve apparatus. Subsequently, percutaneous repair via transcatheter delivered systems has emerged as the treatment of choice; especially, in patients assessed to be at a high operative risk with a suitable anatomy for minimally invasive approaches to re-appose the mitral leaflets3. This has also revolutionized the approach to the management of primary mitral regurgitation (PMR), such as from mitral valve prolapse. It was treated conventionally by the surgical intervention with mitral valve repair or replacement, allowing an alternative option for the high surgical risk patients 4.\u0000\u0000In our center, the transcatheter mitral valve repair procedure (MitraClip) has been introduced in the year 2012, providing an option of percutaneous intervention to the patients where MR is unsuitable for the surgical correction. However, persistent symptoms may occur due to the concomitant non-valvular or non-cardiac pathologies, particularly chronic pulmonary diseases. Also, assessment of functional class is subjective and may be confounded by other variables, such as sedentary lifestyle, self-imposed exercise restrictions, or orthopedic conditions.\u0000\u0000The cardiopulmonary exercise test (CPET) provides an objective assessment of the exercise capacity, obviating the subjective aspects of self-reported symptoms and functional status Besides, CPET is also useful to discern pulmonary and functional status. \u0000\u0000Besides, CPET is also useful to discern pulmonary and non-cardiac contributory components of the perceived decreased functional capacity, including motivational factors.\u0000\u0000Multiple CPET parameters, related to hemodynamic surrogates before and after the MitraClip procedure, also enable a more objective evaluation of the cardiovascular impact of the repair, allowing insights into the improvements in cardiac hemodynamics post intervention7-10.","PeriodicalId":75000,"journal":{"name":"The European journal of cardiovascular medicine","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44003281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Severe Coronary Artery Disease and Metabolic Syndrome in Patients with Acute Coronary Syndrome 急性冠状动脉综合征患者的严重冠状动脉疾病和代谢综合征
Pub Date : 2020-05-18 DOI: 10.5083/ejcm20424884.17
Gul Zaman Khan Niazi, Syed Tahseen Shehzad, A. Akhtar, M. S. Saleemi
{"title":"Severe Coronary Artery Disease and Metabolic Syndrome in Patients with Acute Coronary Syndrome","authors":"Gul Zaman Khan Niazi, Syed Tahseen Shehzad, A. Akhtar, M. S. Saleemi","doi":"10.5083/ejcm20424884.17","DOIUrl":"https://doi.org/10.5083/ejcm20424884.17","url":null,"abstract":"","PeriodicalId":75000,"journal":{"name":"The European journal of cardiovascular medicine","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43659207","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Permanent Complete Heart Block After Kaala Pathar (Paraphenylene Diamine) Poisoning: A Case Report Kaala Pathar(对苯二胺)中毒后永久性完全性心脏传导阻滞1例报告
Pub Date : 2020-05-14 DOI: 10.5083/ejcm20424884.172
S. Saleemi, A. Akhtar
Kaala Patthar, containing paraphenylene diamine (PPD) chemically, is used as a hair dye in South Punjab. Recent trends have shown its increasing use as a poison. The common manifestations of Kala Patthar poisoning include upper airway edema, rhabdomyolysis, and acute renal shutdown. However, cardiac toxicity is a rare complication and the conduction abnormalities are seldom reported. We are going to report a case of permanent complete heart block after Kaala Patthar poisoning where the patient needed permanent pacemaker to save his life.
Kaala Patthar化学成分含有对苯二胺(PPD),在旁遮普省南部被用作染发剂。最近的趋势表明,它作为一种毒药的使用越来越多。卡拉帕塔尔中毒的常见表现包括上呼吸道水肿、横纹肌溶解症和急性肾功能衰竭。然而,心脏毒性是一种罕见的并发症,传导异常的报道很少。我们将报告一例Kaala Patthar中毒后出现永久性完全性心脏传导阻滞的病例,患者需要永久性起搏器来挽救生命。
{"title":"Permanent Complete Heart Block After Kaala Pathar (Paraphenylene Diamine) Poisoning: A Case Report","authors":"S. Saleemi, A. Akhtar","doi":"10.5083/ejcm20424884.172","DOIUrl":"https://doi.org/10.5083/ejcm20424884.172","url":null,"abstract":"Kaala Patthar, containing paraphenylene diamine (PPD) chemically, is used as a hair dye in South Punjab. Recent trends have shown its increasing use as a poison. The common manifestations of Kala Patthar poisoning include upper airway edema, rhabdomyolysis, and acute renal shutdown. However, cardiac toxicity is a rare complication and the conduction abnormalities are seldom reported. We are going to report a case of permanent complete heart block after Kaala Patthar poisoning where the patient needed permanent pacemaker to save his life.","PeriodicalId":75000,"journal":{"name":"The European journal of cardiovascular medicine","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48386249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of Breast Arterial Calcification Presence and Gradation with the Ankle-Brachial Index among Postmenopausal Women. 绝经后妇女乳房动脉钙化的存在和渐变与踝肱指数的关系
Pub Date : 2018-11-01 Epub Date: 2018-11-16
Carlos Iribarren, Gabriela Sanchez, Meng Lu, Fatemeh Azamian Bidgoli, Hyo-Min Cho, Huanjun Ding, Sabee Molloi

Objective: To examine the association of breast arterial calcification (BAC) with the ankle brachial index (ABI), a sensitive metric of peripheral arterial disease (PAD), among postmenopausal women. Background: BAC is an emerging risk marker of cardiovascular disease (CVD).

Methods: MINERVA (MultIethNic study of brEast aRterial calcium gradation and cardioVAscular disease) is a cohort of women aged 60 to 79 at baseline (10/24/2012 - 2/13/2015) who were free of symptomatic CVD at baseline. The analytical sample comprised 3,800 women with available ABI, BAC assessment and covariates. We performed cross-sectional logistic regression analysis.

Results: 203 women (5.3%) had an ABI < 0.90 indicative of PAD, 26 (0.7%) had an ABI > 1.3 and 94% (n=3,571) had an ABI within normal limits. After adjustment for age, race/ethnicity, body mass index, smoking status, diabetes, hypertension, LDL-C, HDL-C, hs-CRP, estimated-GFR, urinary albumin/creatinine ratio, serum calcium, serum vitamin D and serum PTH, BAC presence remained significantly associated with ABI < 0.90 (OR=1.37; 95% CI, 1.01-1.87; p=0.04). After further adjustment for menopausal hormone therapy, parity and history of breast feeding, the association became marginally significant (OR=1.36; 95% CI, 0.99-1.85; p=0.05). No clear pattern of association was observed for increased gradation of BAC and ABI<0.9, and no significant associations were noted between BAC presence vs. absence or BAC gradation with ABI > 1.3.

Conclusions: Among asymptomatic postmenopausal women, presence of BAC was associated with PAD independently of traditional risk factors. Additional prospective studies are required to establish the value of BAC for prediction of incident PAD in the general population.

目的研究绝经后女性乳房动脉钙化(BAC)与踝肱指数(ABI)的关系,踝肱指数是外周动脉疾病(PAD)的敏感指标。背景:BAC是一种新出现的心血管疾病(CVD)风险标志物:MINERVA(东方三尖瓣钙分级和心血管疾病多伦理研究)是一个基线年龄为 60 至 79 岁(2012 年 10 月 24 日至 2015 年 2 月 13 日)、基线时无症状心血管疾病的女性队列。分析样本包括 3,800 名有 ABI、BAC 评估和协变量的女性。我们进行了横截面逻辑回归分析。结果:203 名女性(5.3%)的 ABI 值小于 0.90,表明患有 PAD;26 名女性(0.7%)的 ABI 值大于 1.3;94% 的女性(n=3,571)的 ABI 值在正常范围内。在对年龄、种族/民族、体重指数、吸烟状况、糖尿病、高血压、低密度脂蛋白胆固醇、高密度脂蛋白胆固醇、hs-CRP、估计-GFR、尿白蛋白/肌酐比率、血清钙、血清维生素 D 和血清 PTH 进行调整后,BAC 的存在仍与 ABI < 0.90 显著相关(OR=1.37;95% CI,1.01-1.87;P=0.04)。在对绝经激素治疗、奇偶性和哺乳史进行进一步调整后,这种关联变得略微显著(OR=1.36;95% CI,0.99-1.85;P=0.05)。BAC 和 ABI 1.3 的分级增加没有观察到明显的关联模式:在无症状的绝经后妇女中,BAC的存在与PAD相关,而与传统的风险因素无关。需要进行更多的前瞻性研究,以确定 BAC 在预测普通人群中发生 PAD 的价值。
{"title":"Association of Breast Arterial Calcification Presence and Gradation with the Ankle-Brachial Index among Postmenopausal Women.","authors":"Carlos Iribarren, Gabriela Sanchez, Meng Lu, Fatemeh Azamian Bidgoli, Hyo-Min Cho, Huanjun Ding, Sabee Molloi","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To examine the association of breast arterial calcification (BAC) with the ankle brachial index (ABI), a sensitive metric of peripheral arterial disease (PAD), among postmenopausal women. Background: BAC is an emerging risk marker of cardiovascular disease (CVD).</p><p><strong>Methods: </strong>MINERVA (MultIethNic study of brEast aRterial calcium gradation and cardioVAscular disease) is a cohort of women aged 60 to 79 at baseline (10/24/2012 - 2/13/2015) who were free of symptomatic CVD at baseline. The analytical sample comprised 3,800 women with available ABI, BAC assessment and covariates. We performed cross-sectional logistic regression analysis.</p><p><strong>Results: </strong>203 women (5.3%) had an ABI < 0.90 indicative of PAD, 26 (0.7%) had an ABI > 1.3 and 94% (n=3,571) had an ABI within normal limits. After adjustment for age, race/ethnicity, body mass index, smoking status, diabetes, hypertension, LDL-C, HDL-C, hs-CRP, estimated-GFR, urinary albumin/creatinine ratio, serum calcium, serum vitamin D and serum PTH, BAC presence remained significantly associated with ABI < 0.90 (OR=1.37; 95% CI, 1.01-1.87; p=0.04). After further adjustment for menopausal hormone therapy, parity and history of breast feeding, the association became marginally significant (OR=1.36; 95% CI, 0.99-1.85; p=0.05). No clear pattern of association was observed for increased gradation of BAC and ABI<0.9, and no significant associations were noted between BAC presence vs. absence or BAC gradation with ABI > 1.3.</p><p><strong>Conclusions: </strong>Among asymptomatic postmenopausal women, presence of BAC was associated with PAD independently of traditional risk factors. Additional prospective studies are required to establish the value of BAC for prediction of incident PAD in the general population.</p>","PeriodicalId":75000,"journal":{"name":"The European journal of cardiovascular medicine","volume":"5 5","pages":"544-551"},"PeriodicalIF":0.0,"publicationDate":"2018-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385879/pdf/nihms-997891.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10444805","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The safety and Efficacy of smoking cessation treatments 戒烟治疗的安全性和有效性
Pub Date : 2017-03-03 DOI: 10.5083//ejcm.20424884.154
M. Eisenberg
{"title":"The safety and Efficacy of smoking cessation treatments","authors":"M. Eisenberg","doi":"10.5083//ejcm.20424884.154","DOIUrl":"https://doi.org/10.5083//ejcm.20424884.154","url":null,"abstract":"","PeriodicalId":75000,"journal":{"name":"The European journal of cardiovascular medicine","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2017-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47937354","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Refining the Enrolment Process in Emergency Medicine Research. 完善急诊医学研究的注册流程。
Pub Date : 2016-04-01 DOI: 10.5083/ejcm.20424884.147
Kate M Sahan, Keith M Channon, Robin P Choudhury, Rajesh K Kharbanda, Regent Lee, Mark Sheehan

Research in the emergency setting involving patients with acute clinical conditions is needed if there are to be advances in diagnosis and treatment. But research in these areas poses ethical and practical challenges. One of these is the general inability to obtain informed consent due to the patient's lack of mental capacity and insufficient time to contact legal representatives. Regulatory frameworks which allow this research to proceed with a consent 'waiver', provided patients lack mental capacity, miss important ethical subtleties. One of these is the varying nature of mental capacity among emergency medicine patients. Not only is their capacity variable and often unclear, but some patients are also likely to be able to engage with the researcher and the context to varying degrees. In this paper we describe the key elements of a novel enrolment process for emergency medicine research that refines the consent waiver and fully engages with the ethical rationale for consent and, in this context, its waiver. The process is verbal but independently documented during the 'emergent' stages of the research. It provides appropriate engagement with the patient, is context-sensitive and better addresses ethical subtleties. In line with regulation, full written consent for on-going participation in the research is obtained once the emergency is passed.

要想在诊断和治疗方面取得进展,就必须在急诊环境中开展涉及急性临床症状患者的研究。但是,这些领域的研究面临着伦理和实际挑战。其中一个挑战是,由于病人缺乏心智能力,也没有足够的时间联系法律代表,因此一般无法获得知情同意。监管框架允许在病人缺乏精神行为能力的情况下,在 "放弃 "同意的情况下进行这项研究,但却忽略了重要的伦理微妙之处。其中之一就是急诊科病人的精神行为能力各不相同。不仅他们的行为能力参差不齐,而且往往不明确,有些病人还可能在不同程度上能够与研究人员和研究环境互动。在本文中,我们介绍了一种新颖的急诊医学研究注册流程的关键要素,该流程完善了同意弃权,并充分考虑了同意的伦理依据,以及在这种情况下同意弃权的伦理依据。在研究的 "紧急 "阶段,该过程是口头的,但有独立的记录。它能让患者适当参与,对具体情况有敏感认识,并能更好地解决伦理方面的微妙问题。根据规定,一旦紧急情况过去,将获得继续参与研究的完全书面同意。
{"title":"Refining the Enrolment Process in Emergency Medicine Research.","authors":"Kate M Sahan, Keith M Channon, Robin P Choudhury, Rajesh K Kharbanda, Regent Lee, Mark Sheehan","doi":"10.5083/ejcm.20424884.147","DOIUrl":"10.5083/ejcm.20424884.147","url":null,"abstract":"<p><p>Research in the emergency setting involving patients with acute clinical conditions is needed if there are to be advances in diagnosis and treatment. But research in these areas poses ethical and practical challenges. One of these is the general inability to obtain informed consent due to the patient's lack of mental capacity and insufficient time to contact legal representatives. Regulatory frameworks which allow this research to proceed with a consent 'waiver', provided patients lack mental capacity, miss important ethical subtleties. One of these is the varying nature of mental capacity among emergency medicine patients. Not only is their capacity variable and often unclear, but some patients are also likely to be able to engage with the researcher and the context to varying degrees. In this paper we describe the key elements of a novel enrolment process for emergency medicine research that refines the consent waiver and fully engages with the ethical rationale for consent and, in this context, its waiver. The process is verbal but independently documented during the 'emergent' stages of the research. It provides appropriate engagement with the patient, is context-sensitive and better addresses ethical subtleties. In line with regulation, full written consent for on-going participation in the research is obtained once the emergency is passed.</p>","PeriodicalId":75000,"journal":{"name":"The European journal of cardiovascular medicine","volume":"4 1","pages":"506-510"},"PeriodicalIF":0.0,"publicationDate":"2016-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975512/pdf/emss-68476.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34642905","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Using The Descending Aortic Wall Thickness Measured In Transesophageal Echocardiography As A Risk Marker For Aortic Dissection. 应用经食管超声心动图测量的降主动脉壁厚度作为主动脉夹层的危险指标。
Pub Date : 2015-04-30 DOI: 10.5083/ejcm.20424884.136
Zaher Fanari, Sumaya Hammami, Muhammad Baraa Hammami, Safa Hammami, Chete Eze-Nliam, William S Weintraub

Objective: The aim of this study is to estimate whether aortic wall thickness is increased in patients with Aortic dissection (AD) compared to low risk control group and can be used in addition to aortic diameter as a risk marker of AD.

Background: AD occurs due to pathologies that may increase thickness of the aortic wall. Transesophageal echocardiography (TEE) has the ability to visualize both the thoracic aortic wall and lumen. Aortic diameter has been used to predict aortic dissection and timing of surgery, but it is not always predictive of that risk.

Methods: In 48 patients with AD who underwent TEE were examined retrospectively and compared to 48 control patients with patent foramen ovale (PFO). We measured aortic diameter at different levels, intimal/medial thickness (IMT) and complete wall thickness (CMT). Demographic data and cardiovascular risk factors were reviewed. The data was analyzed using ANOVA and student t test.

Results: (AD) patients were older [mean age 66 AD vs. 51 PFO], had more hypertension, diabetes, hyperlipidemia and Coronary artery disease. Both IMT and CMT in the descending aorta were increased in AD group [(1.85 vs. 1.43 mm; P=0.03 and 2.93 vs. 2.46 mm; p=0.01). As expected the diameter of ascending aorta was also greater in AD (4.61 vs. 2.92 cm; P=0.004).

Conclusions: CMT and IMT in the descending aorta detected by TEE is greater in patients with AD when compared to control and may add prognostic data to that of aortic diameter.

目的:本研究旨在评估主动脉夹层(aortic dissection, AD)患者的主动脉壁厚度是否比低风险对照组增加,并可作为除主动脉直径外AD的风险指标。背景:AD的发生是由于病变可能增加主动脉壁的厚度。经食管超声心动图(TEE)能够同时显示胸主动脉壁和管腔。主动脉直径被用来预测主动脉夹层和手术时机,但它并不总是预测这种风险。方法:回顾性分析48例经TEE治疗的AD患者,并与对照组48例卵圆孔未闭(PFO)患者进行比较。我们测量了不同水平的主动脉直径、内膜/内侧厚度(IMT)和完全壁厚(CMT)。回顾了人口统计数据和心血管危险因素。数据分析采用方差分析和学生t检验。结果:(AD)患者年龄较大[平均年龄66 AD vs 51 PFO],高血压、糖尿病、高脂血症和冠状动脉疾病较多。AD组降主动脉IMT和CMT均升高[(1.85 vs. 1.43 mm;P=0.03和2.93 vs. 2.46 mm;p = 0.01)。正如预期的那样,AD患者升主动脉直径也更大(4.61比2.92 cm;P = 0.004)。结论:TEE检测的AD患者降主动脉CMT和IMT高于对照组,并可能在主动脉直径的基础上增加预后数据。
{"title":"Using The Descending Aortic Wall Thickness Measured In Transesophageal Echocardiography As A Risk Marker For Aortic Dissection.","authors":"Zaher Fanari,&nbsp;Sumaya Hammami,&nbsp;Muhammad Baraa Hammami,&nbsp;Safa Hammami,&nbsp;Chete Eze-Nliam,&nbsp;William S Weintraub","doi":"10.5083/ejcm.20424884.136","DOIUrl":"https://doi.org/10.5083/ejcm.20424884.136","url":null,"abstract":"<p><strong>Objective: </strong>The aim of this study is to estimate whether aortic wall thickness is increased in patients with Aortic dissection (AD) compared to low risk control group and can be used in addition to aortic diameter as a risk marker of AD.</p><p><strong>Background: </strong>AD occurs due to pathologies that may increase thickness of the aortic wall. Transesophageal echocardiography (TEE) has the ability to visualize both the thoracic aortic wall and lumen. Aortic diameter has been used to predict aortic dissection and timing of surgery, but it is not always predictive of that risk.</p><p><strong>Methods: </strong>In 48 patients with AD who underwent TEE were examined retrospectively and compared to 48 control patients with patent foramen ovale (PFO). We measured aortic diameter at different levels, intimal/medial thickness (IMT) and complete wall thickness (CMT). Demographic data and cardiovascular risk factors were reviewed. The data was analyzed using ANOVA and student t test.</p><p><strong>Results: </strong>(AD) patients were older [mean age 66 AD vs. 51 PFO], had more hypertension, diabetes, hyperlipidemia and Coronary artery disease. Both IMT and CMT in the descending aorta were increased in AD group [(1.85 vs. 1.43 mm; P=0.03 and 2.93 vs. 2.46 mm; p=0.01). As expected the diameter of ascending aorta was also greater in AD (4.61 vs. 2.92 cm; P=0.004).</p><p><strong>Conclusions: </strong>CMT and IMT in the descending aorta detected by TEE is greater in patients with AD when compared to control and may add prognostic data to that of aortic diameter.</p>","PeriodicalId":75000,"journal":{"name":"The European journal of cardiovascular medicine","volume":"3 1","pages":"448-451"},"PeriodicalIF":0.0,"publicationDate":"2015-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429792/pdf/nihms687080.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33187148","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
The European journal of cardiovascular medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1